How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Anthropic’s Claude is helping the company develop the next, more intelligent version of the model, the artificial intelligence lab said in an announcement Thursday. Claude is leading 26% of ...

Beijing called the warnings "fear mongering" as President Donald Trump argued that slowing down would cost the U.S. its lead over China ...

The titans of the AI industry have the resources to set up an emergency response mechanism for a rogue agent. So why aren't they doing it? The post Trump and Xi Have No Joint Plan for a Rogue AI ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund 6.56M Jun 30, 2026 1.22% 23,112,925 ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...